about
Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasisExpression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patientsEffects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice.Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells.Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasisBile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress.Valproic acid downregulates heme oxygenase-1 independently of Nrf2 by increasing ubiquitination and proteasomal degradation.IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats.Carcinoembryonic antigen-related cell adhesion molecule 1 is the 85-kilodalton pronase-resistant biliary glycoprotein in the cholesterol crystallization promoting low density protein-lipid complex.The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats.Protective effects of inhaled carbon monoxide in endotoxin-induced cholestasis is dependent on its kinetics.Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues.Introduction of water into the heme distal side by Leu65 mutations of an oxygen sensor, YddV, generates verdoheme and carbon monoxide, exerting the heme oxygenase reaction.Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora.Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection.Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo.Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis.Antiproliferative effects of carbon monoxide on pancreatic cancer.Chlorophyll-Mediated Changes in the Redox Status of Pancreatic Cancer Cells Are Associated with Its Anticancer EffectsHeme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside CompositionHepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: Relationship to HO-1/CO antioxidant systemHYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharideXanthene-9-carboxylic acid: A photo-activatable transition-metal-free carbon monoxide-releasing molecule with extraordinary long half-lifeIsolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in MiceUrinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndromeAssociation of systemic lupus erythematosus with low serum bilirubin levelsStatin use and serum bilirubin levelsTransition-Metal-Free CO-Releasing BODIPY Derivatives Activatable by Visible to NIR Light as Promising Bioactive MoleculesCobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood.Hyperbilirubinemia in Gunn Rats is Associated with Decreased Inflammatory Response in LPS-Mediated Systemic Inflammation
P50
Q28393256-84F9CCB8-A107-454D-9977-3FC5D74AE292Q34638990-5CBDAB77-5091-4DBA-AC1F-60B1D33D4252Q35332431-E92DBEAC-DC41-4380-97C1-4C2083A45002Q36016816-B03B7A8F-4D2B-4CBA-B963-0812024FECE4Q37087420-13BDDD7B-E6B4-43A9-AB52-FB22FC8471F7Q37294067-0F4CC3DF-8848-4022-8B91-9B6F609B9011Q38716817-1A053C25-58A7-4DE8-AB07-D7E478279D50Q41601248-D1FA3295-458C-4416-8645-E53786CCD85DQ43814799-149C6D48-C342-418E-90C9-BA4E95F51FA2Q45256535-5255DF84-A5AA-4F76-B420-50F4B5CF9E9BQ45334894-A314AD96-FD75-46EC-958F-98E68F11823FQ46676200-FFF65349-2D7B-4102-B37E-56CEF25E8F66Q46863741-8041D5F9-4CAE-4D28-B5AC-6A7DEA223B0AQ46965912-4511A577-9DF1-49CD-A6E9-F90546754E22Q46976972-6326260E-E853-439C-9DEA-9855AF1E6F34Q48606292-791E5CC5-99C0-4862-A96A-EB3BD8C842DCQ50229330-A833D04F-642F-4B62-9245-33317D45A1C0Q53243546-FDFCB5CE-7A21-43BD-8A59-5062652340D0Q57115413-69DD237D-E868-47A9-AD29-4F3BF0A7A56EQ57493003-11B33226-4F7F-4908-AFA6-45BB78179827Q57557780-64817C0D-1A99-4F5B-A749-3148C9DFD9F1Q58550047-4B8B0024-6172-49E4-A775-657BC56DC122Q63400439-4AD68BC7-A9C6-483B-A5A3-6B97C36BF0B3Q64229422-933A5183-53F4-4A30-A65C-9FECA752BA0FQ80470882-6EC830E0-90D1-487C-911F-AD659D1E914BQ84529184-D7C77A44-8E4C-4B31-82BC-E3D3D2F72BB2Q85046441-570830E5-EF69-49B2-9943-A4E11C06630EQ86961955-C1986E26-62B5-4832-95C1-32B7625500D3Q90923689-43A8CD41-391A-4A93-814C-C00AE316591BQ91924929-8FD6AB5C-9864-412A-84FA-7A9A89038754
P50
description
biochemička, patobiochemička
@cs
researcher ORCID ID = 0000-0003-2082-1060
@en
wetenschapper
@nl
name
Lucie Muchová
@ast
Lucie Muchová
@cs
Lucie Muchová
@en
Lucie Muchová
@es
Lucie Muchová
@nl
type
label
Lucie Muchová
@ast
Lucie Muchová
@cs
Lucie Muchová
@en
Lucie Muchová
@es
Lucie Muchová
@nl
prefLabel
Lucie Muchová
@ast
Lucie Muchová
@cs
Lucie Muchová
@en
Lucie Muchová
@es
Lucie Muchová
@nl
P106
P214
P1153
6602707616
P21
P214
P31
P496
0000-0003-2082-1060